Top

Published in:

01-10-2013 | Review Article

Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography

Authors: K. Bratis, MD, I. Mahmoud, MD, A. Chiribiri, MD, PhD, E. Nagel, MD, PhD, FACC, FESC, MRCR

Published in: Journal of Nuclear Cardiology | Issue 5/2013

Abstract

Recent studies have demonstrated that a detailed knowledge of the extent of angiographic coronary artery disease (CAD) is not a prerequisite for clinical decision making, and the clinical management of patients with CAD is more and more focused towards the identification of myocardial ischemia and the quantification of ischemic burden. In this view, non-invasive assessment of ischemia and in particular stress imaging techniques are emerging as preferred and non-invasive options. A quantitative assessment of regional myocardial perfusion can provide an objective estimate of the severity of myocardial injury and may help clinicians to discriminate regions of the heart that are at increased risk for myocardial infarction. Positron emission tomography (PET) has established itself as the reference standard for myocardial blood flow (MBF) and myocardial perfusion reserve (MPR) quantification. Cardiac magnetic resonance (CMR) is increasingly used to measure MBF and MPR by means of first-pass signals, with a well-defined diagnostic performance and prognostic value. The aim of this article is to review the currently available evidence on the use of both PET and CMR for quantification of MPR, with particular attention to the studies that directly compared these two diagnostic methods.

Piek JJ, Boersma E, di Mario C, Schroeder E, Vrints C, Probst P, et al. Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J 2000;21:466-74.PubMedCrossRef

Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:459-74.PubMedCrossRef

Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.PubMedCrossRef

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.PubMedCrossRef

Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.PubMedCrossRef

Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.PubMedCrossRef

De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.PubMedCrossRef

Christian TF, Rettmann DW, Aletras AH, Liao SL, Taylor JL, Balaban RS, et al. Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology 2004;232:677-84.PubMedCrossRef

Berman DS, Kang X, Gransar H, Gerlach J, Friedman JD, Hayes SW, et al. Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol 2009;16:45-53.PubMedCrossRef

10.

Zaacks SM, Ali A, Parrillo JE, Barron JT. How well does radionuclide dipyridamole stress testing detect three-vessel coronary artery disease and ischemia in the region supplied by the most stenotic vessel? Clin Nucl Med 1999;24:35-41.PubMedCrossRef

11.

Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007;14:521-8.PubMedCrossRef

12.

Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830-40.PubMedCrossRef

13.

Patel AR, Epstein FH, Kramer CM. Evaluation of the microcirculation: Advances in cardiac magnetic resonance perfusion imaging. J Nucl Cardiol 2008;15:698-708.PubMedCrossRef

14.

Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-83.PubMedCrossRef

15.

Hsu LY, Groves DW, Aletras AH, Kellman P, Arai AE. A quantitative pixel-wise measurement of myocardial blood flow by contrast-enhanced first-pass CMR perfusion imaging: microsphere validation in dogs and feasibility study in humans. JACC Cardiovasc Imaging 2012;5:154-66.PubMedCrossRef

16.

Muzik O, Duvernoy C, Beanlands RS, Sawada S, Dayanikli F, Wolfe ER Jr, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31:534-40.PubMedCrossRef

17.

Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med 2009;50:1076-87.PubMedCrossRef

18.

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124:2215-24.PubMedCrossRef

19.

Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991;18:959-65.PubMedCrossRef

20.

Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE, et al. Myocardial perfusion reserve: Assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-84.PubMed

21.

Jerosch-Herold M, Kwong RY. Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease. Curr Opin Cardiol 2008;23:599-606.PubMedCrossRef

22.

Nagel E, al-Saadi N, Fleck E. Cardiovascular magnetic resonance: Myocardial perfusion. Herz 2000;25:409-16.PubMedCrossRef

23.

Cullen JH, Horsfield MA, Reek CR, Cherryman GR, Barnett DB, Samani NJ. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33:1386-94.PubMedCrossRef

24.

Gebker R, Schwitter J, Fleck E, Nagel E. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007;9:539-47.PubMedCrossRef

25.

Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-7.PubMedCrossRef

26.

al-Saadi N, Gross M, Bornstedt A, Schnackenburg B, Klein C, Fleck E, et al. Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography. Z Kardiol 2001;90:824-34.PubMedCrossRef

27.

Ishida M, Ichihara T, Nagata M, Ishida N, Takase S, Kurita T, et al. Quantification of myocardial blood flow using model based analysis of first-pass perfusion MRI: Extraction fraction of Gd-DTPA varies with myocardial blood flow in human myocardium. Magn Reson Med 2011;66:1391-9.PubMedCrossRef

28.

Patel AR, Antkowiak PF, Nandalur KR, West AM, Salerno M, Arora V, et al. Assessment of advanced coronary artery disease: Advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol 2010;56:561-9.PubMedCrossRef

29.

Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998;25:73-84.PubMedCrossRef

30.

Zun Z, Wong EC, Nayak KS. Assessment of myocardial blood flow (MBF) in humans using arterial spin labeling (ASL): Feasibility and noise analysis. Magn Reson Med 2009;62:975-83.PubMedCrossRef

31.

Arnold JR, Karamitsos TD, Pegg TJ, Francis JM, Olszewski R, Searle N, et al. Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: A comparison with coronary angiography and cardiac magnetic resonance. JACC Cardiovasc Imaging 2010;3:934-43.PubMedCrossRef

32.

Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: Comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-9.PubMedCrossRef

33.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60.PubMedCrossRef

34.

Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.PubMedCrossRef

35.

Ibrahim T, Nekolla SG, Schreiber K, Odaka K, Volz S, Mehilli J, et al. Assessment of coronary flow reserve: Comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 2002;39:864-70.PubMedCrossRef

36.

Parkka JP, Niemi P, Saraste A, Koskenvuo JW, Komu M, Oikonen V, et al. Comparison of MRI and positron emission tomography for measuring myocardial perfusion reserve in healthy humans. Magn Reson Med 2006;55:772-9.PubMedCrossRef

37.

Morton G, Chiribiri A, Ishida M, Hussain ST, Schuster A, Indermuehle A, et al. Quantification of absolute myocardial perfusion in patients with coronary artery disease: Comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol 2012;60:1546-55.PubMedCrossRef

38.

Fritz-Hansen T, Hove JD, Kofoed KF, Kelbaek H, Larsson HB. Quantification of MRI measured myocardial perfusion reserve in healthy humans: A comparison with positron emission tomography. J Magn Reson Imaging 2008;27:818-24.PubMedCrossRef

39.

Costa MA, Shoemaker S, Futamatsu H, Klassen C, Angiolillo DJ, Nguyen M, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol 2007;50:514-22.PubMedCrossRef

40.

Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2011;57:70-5.PubMedCrossRef

41.

Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, et al. Prognostic value of cardiac magnetic resonance stress tests: Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76.PubMedCrossRef

42.

Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-32.PubMedCrossRef

43.

Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-8.PubMedCrossRef

44.

Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007;50:1174-9.PubMedCrossRef

45.

Saraste A, Kajander S, Han C, Nesterov SV, Knuuti J. PET: Is myocardial flow quantification a clinical reality? J Nucl Cardiol 2012;19:1044-59.PubMedCrossRef

46.

Schwaiger M, Hutchins G. Quantification of regional myocardial perfusion by PET: Rationale and first clinical results. Eur Heart J 1995;16:84-91.PubMedCrossRef

47.

Beanlands RS, Muzik O, Melon P, Sutor R, Sawada S, Muller D, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995;26:1465-75.PubMedCrossRef

48.

Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.PubMedCrossRef

49.

Keereman V, Holen RV, Mollet P, Vandenberghe S. The effect of errors in segmented attenuation maps on PET quantification. Med Phys 2011;38:6010-9.PubMedCrossRef

50.

Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of ¹³N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMedCrossRef

51.

Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.PubMedCrossRef

52.

Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858-68.PubMedCrossRef

53.

Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.PubMedCrossRef

54.

Uren NG, Camici PG, Melin JA, Bol A, de Bruyne B, Radvan J, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032-6.PubMed

55.

Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233-8.PubMedCrossRef

56.

Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-9.PubMedCrossRef

57.

Sambuceti G, Parodi O, Marzullo P, Giorgetti A, Fusani L, Puccini G, et al. Regional myocardial blood flow in stable angina pectoris associated with isolated significant narrowing of either the left anterior descending or left circumflex coronary artery. Am J Cardiol 1993;72:990-4.PubMedCrossRef

58.

Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: Results from a multicenter observational registry. J Am Coll Cardiol 2013;61:176-84.PubMedCrossRef

59.

Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993;21:612-21.PubMedCrossRef

60.

Schwarz ER, Speakman MT, vom Dahl J, Kloner RA. Hibernating myocardium: Is there evidence for chronic flow reduction? Heart Dis 1999;1:155-62.PubMed

61.

Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.PubMedCrossRef

62.

Choudhury L, Elliott P, Rimoldi O, Ryan M, Lammertsma AA, Boyd H, et al. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. Basic Res Cardiol 1999;94:49-59.PubMedCrossRef

63.

Gistri R, Cecchi F, Choudhury L, Montereggi A, Sorace O, Salvadori PA, et al. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol 1994;74:363-8.PubMedCrossRef

64.

Jorg-Ciopor M, Namdar M, Turina J, Jenni R, Schwitter J, Turina M, et al. Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy. J Thorac Cardiovasc Surg 2004;128:163-9.PubMedCrossRef

65.

Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.PubMedCrossRef

66.

Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kubler W. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: Analysis of 16 patients. Am J Cardiol 1983;51:1657-62.PubMedCrossRef

67.

Stolen KQ, Kemppainen J, Kalliokoski KK, Karanko H, Toikka J, Janatuinen T, et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:64-8.PubMedCrossRef

68.

Canetti M, Akhter MW, Lerman A, Karaalp IS, Zell JA, Singh H, et al. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92:1246-9.PubMedCrossRef

69.

Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.PubMedCrossRef

70.

Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis. J Am Coll Cardiol 2012;59:1719-28.PubMedCrossRef

71.

Nielsen G, Fritz-Hansen T, Dirks CG, Jensen GB, Larsson HB. Evaluation of heart perfusion in patients with acute myocardial infarction using dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004;20:403-10.PubMedCrossRef

72.

Pack NA, DiBella EV, Rust TC, Kadrmas DJ, McGann CJ, Butterfield R, et al. Estimating myocardial perfusion from dynamic contrast-enhanced CMR with a model-independent deconvolution method. J Cardiovasc Magn Reson 2008;10:52.PubMedCrossRef

73.

Plein S, Kozerke S, Suerder D, Luescher TF, Greenwood JP, Boesiger P, et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008;29:2148-55.PubMedCrossRef

74.

Araoz PA, Glockner JF, McGee KP, Potter DD Jr, Valeti VU, Stanley DW, et al. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 2005;7:559-64.PubMedCrossRef

75.

Shin T, Hu HH, Pohost GM, Nayak KS. Three dimensional first-pass myocardial perfusion imaging at 3 T: Feasibility study. J Cardiovasc Magn Reson 2008;10:57.PubMedCrossRef

76.

Machac J. Cardiac positron emission tomography imaging. Semin Nucl Med 2005;35:17-36.PubMedCrossRef

77.

Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2009;2:412-24.PubMedCrossRef

78.

Garcia EV. Physical attributes, limitations, and future potential for PET and SPECT. J Nucl Cardiol 2012;19:S19-29.PubMedCrossRef

79.

Algranati D, Kassab GS, Lanir Y. Why is the subendocardium more vulnerable to ischemia? A new paradigm. Am J Physiol Heart Circ Physiol 2011;300:H1090-100.PubMedCrossRef

80.

Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.PubMedCrossRef

81.

Muehling OM, Jerosch-Herold M, Panse P, Zenovich A, Wilson BV, Wilson RF, et al. Regional heterogeneity of myocardial perfusion in healthy human myocardium: Assessment with magnetic resonance perfusion imaging. J Cardiovasc Magn Reson 2004;6:499-507.PubMedCrossRef

82.

Muehling OM, Wilke NM, Panse P, Jerosch-Herold M, Wilson BV, Wilson RF, et al. Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003;42:1054-60.PubMedCrossRef

83.

Vermeltfoort IAC, Raijmakers PGHM, et al. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J 2007;28:1554-8.PubMedCrossRef

84.

Miyai N, Kawasaki T, Taniguchi T, Kamitani T, Kawasaki S, Sugihara H. Exercise-induced ST-segment depression and myocardial ischemia in patients with hypertrophic cardiomyopathy: myocardial scintigraphic study. J Cardiol 2005;46:141-7.PubMed

85.

Kawasaki T, Akakabe Y, Yamano M, Miki S, Kamitani T, Kuribayashi T, et al. Gated single-photon emission computed tomography detects subendocardial ischemia in hypertrophic cardiomyopathy. Circ J 2007;71:256-60.PubMedCrossRef

86.

Rajappan K, Rimoldi OE, Dutka DP, Ariff B, Pennell DJ, Sheridan DJ, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002;105:470-6.PubMedCrossRef

87.

Vermeltfoort IA, Raijmakers PG, Lubberink M, Germans T, van Rossum AC, Lammertsma AA, et al. Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography. J Nucl Cardiol 2011;18:650-6.PubMedCrossRef

88.

Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with ¹⁵O-labeled water and PET. J Nucl Med 1999;40:1848-56.PubMed

89.

Nagamachi S, Czernin J, Kim AS, Sun KT, Bottcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996;37:1626-31.PubMed

90.

Jerosch-Herold M, Vazquez G, Wang L, Jacobs DR Jr, Folsom AR. Variability of myocardial blood flow measurements by magnetic resonance imaging in the multi-ethnic study of atherosclerosis. Invest Radiol 2008;43:155-61.PubMedCrossRef

91.

Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJ, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2012;19:670-80.PubMedCrossRef

92.

Jogiya R, Kozerke S, Morton G, De Silva K, Redwood S, Perera D, et al. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol 2012;60:756-65.PubMedCrossRef

93.

Morton G, Ishida M, Schuster A, Hussain S, Schaeffter T, Chiribiri A, et al. Perfusion cardiovascular magnetic resonance: Comparison of an advanced, high-resolution and a standard sequence. J Cardiovasc Magn Reson 2012;14:34.PubMedCrossRef

94.

Schroeder MA, Clarke K, Neubauer S, Tyler DJ. Hyperpolarized magnetic resonance: A novel technique for the in vivo assessment of cardiovascular disease. Circulation 2011;124:1580-94.PubMedCrossRef

95.

Small GR, Wells RG, Schindler T, Chow BJ, Ruddy TD. Advances in cardiac SPECT and PET imaging: Overcoming the challenges to reduce radiation exposure and improve accuracy. Can J Cardiol 2013;29:275-84.PubMedCrossRef

Title: Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography
Authors: K. Bratis, MD
I. Mahmoud, MD
A. Chiribiri, MD, PhD
E. Nagel, MD, PhD, FACC, FESC, MRCR
Publication date: 01-10-2013
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 5/2013
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-013-9762-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

Provisional use of myocardial perfusion imaging in patients undergoing exercise stress testing: A worthy concept fraught with challenges

CME Quiz & Registration Form

Is there a role for myocardial perfusion imaging in patients with an elevated high-sensitivity troponin?

ASNC Model Coverage Policy: Cardiac positron emission tomographic imaging

Deterioration of left ventricular ejection fraction and contraction synchrony during right ventricular pacing in patients with left bundle branch block

ASNC 2013 Education Calendar